Evotec SE 2025 IR
The report outlines Evotec's strategic transition towards an asset-lighter business model, highlighted by the sale of its Just – Evotec Biologics manufacturing site in Toulouse to Sandoz for 350 million USD in cash. Despite a challenging macroeconomic environment, the company achieved revenues of 788.4 million EUR and an adjusted Group EBITDA of 41.1 million EUR. On the sustainability front, Evotec made significant progress by sourcing 99.9% of its electricity from renewable sources and achieving a 65% net reduction in Scope 1 and 2 emissions compared to 2021. Additionally, the company initiated a comprehensive climate risk assessment to strengthen operational resilience.
Company: Evotec SE
Sector: Manufacturing
Country: Germany
Year: 2025
Type: IR
Pages: 215
Evotec SE
The report outlines Evotec's strategic transition towards an asset-lighter business model, highlighted by the sale of its Just – Evotec Biologics manufacturing site in Toulouse to Sandoz for 350 million USD in cash. Despite a challenging macroeconomic environment, the company achieved revenues of 788.4 million EUR and an adjusted Group EBITDA of 41.1 million EUR. On the sustainability front, Evotec made significant progress by sourcing 99.9% of its electricity from renewable sources and achieving a 65% net reduction in Scope 1 and 2 emissions compared to 2021. Additionally, the company initiated a comprehensive climate risk assessment to strengthen operational resilience.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees